Cellex Cell Professionals is hosting the Cellex Symposium 2026 “Cell and Gene Therapy at a Turning Point” with speakers including Prof. Dr. Martin Wermke, Ping Shek, and Dr. Matthias Domogalla.
Published
Signal category
Presence & Recognition
Quote
“This is one of the questions we will explore at the Cellex Symposium 2026 “Cell and Gene Therapy at a Turning Point”.”
— Cellex Cell Professionals team
Company
Cellex Cell Professionals
We care for life!
- Industry
- Biotechnology Research
- Location
- Köln, DE
- Company size
- 233 employees
Cellex Cell Professionals is a full-service CDMO for cell therapy Cellex supports biopharma and academia with a full portfolio of services around cell and gene therapy for research, clinical and commercial use worldwide. Our company has experience in development of cGMP processes, GMP manufacturing of autologous and allogeneic cell therapy products using vectors and LNPs, quality control testing and release. In our state-of-the-art GMP facility cellular subsets can be separated and frozen but also genetically modified and analyzed. All processes are adapted to the customers' needs, based on profound experience with EU and FDA regulations. Cellex also stands for a successful tech transfer of processes from US to Europe. Our apheresis centers have all techniques for collection of different starting materials from healthy donors. Cellex runs its own highly diverse donor pool and offers leukopak, bone marrow or whole blood products customized for R&D, clinical or commercial purposes. IT and transport solutions complete the Cellex portfolio.
Founded 2001